Primer on Multiple Sclerosis
2nd Edition
Published on 17. March 2016
Book
Paperback/Softback
612 pages
978-0-19-934101-6 (ISBN)
Description
Primer on Multiple Sclerosis, 2nd Edition is an updated reference manual for the practicing clinician. It covers the range of information needed to treat persons with MS, beginning with basic science and immunopathology, thorough differential diagnosis, symptom management and disease modifying therapies. This essential book also includes material covering new and experimental strategies as well as a review of commonly used complementary and alternative modalities that are used by persons with MS.Multiple Sclerosis (MS) is the most common demyelinating disease of the CNS and the third most common cause of disability among young adults. The complex management issues that are often present in the care of individuals with MS may demand the participation of health care professionals from a variety of disciplines, although the team is usually led by a neurologist. It is therefore essential for the neurologist to have a thorough grounding in the basic science and clinical phenomenology of MS.
In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics are provided, including new medications that have been FDA- approved since the first edition. Includes new diagnostic criteria, as well as any advances made in current diagnostic techniques, e.g. new imaging metrics. Important new information in the basic sciences and pathophysiology of MS is provided as well as newer epidemiologic studies. Treatment algorithms for common symptoms will be expanded, as well as any new guidelines for switching medications for Disease Modifying treatment "failures". The chapter on alternative and complimentary therapies discusses new research on CCSVI. The chapter on legal issues includes information on the putative effect of the Affordable Health Care Act on access to neurologic care and treatments. Finally, there is expanded discussion of progressive forms of MS both from a basic science and treatment perspective.
In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics are provided, including new medications that have been FDA- approved since the first edition. Includes new diagnostic criteria, as well as any advances made in current diagnostic techniques, e.g. new imaging metrics. Important new information in the basic sciences and pathophysiology of MS is provided as well as newer epidemiologic studies. Treatment algorithms for common symptoms will be expanded, as well as any new guidelines for switching medications for Disease Modifying treatment "failures". The chapter on alternative and complimentary therapies discusses new research on CCSVI. The chapter on legal issues includes information on the putative effect of the Affordable Health Care Act on access to neurologic care and treatments. Finally, there is expanded discussion of progressive forms of MS both from a basic science and treatment perspective.
Reviews / Votes
This new volume provides a highly accessible summary of a most dynamic area of medicine, featuring updates by many leading authorities in the field. The new edition of Dr. Geisser's primer has great practical value for all clinicians who care for people with multiple sclerosis. * - Stephen L. Hauser, MD Professor & Chair, Department of Neurology, University of California, San Francisco, CA * Dr. Barbara S. Giesser's second edition of Primer On Multiple Sclerosis is an impressive and highly successful comprehensive review and synthesis of the huge scientific literature concerning multiple sclerosis. In reading it, one will come to appreciate the remarkable progress we have made and, yet, how much further we still have to go to eliminate this disease from the myriad of sufferings mankind is faced with. I know of no better resource to educate sophisticated patients, clinicians, researchers and health policy advocates about MS. * Timothy Vollmer, MD, Co-Director, RMMSC at Anschutz Medical Director, RMMSC, Director, Neurology Clinical Research, Professor, Department of Neurology, Aurora, CO *More details
Edition
2nd Revised edition
Language
English
Place of publication
New York
United States
Target group
Professional and scholarly
Edition type
Revised edition
Dimensions
Height: 254 mm
Width: 178 mm
Thickness: 33 mm
Weight
1138 gr
ISBN-13
978-0-19-934101-6 (9780199341016)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Barbara S. Giesser
Primer on Multiple Sclerosis
E-Book
01/2016
2nd Edition
OUP eBook
€86.99
Available for download
Barbara S. Giesser
Primer on Multiple Sclerosis
E-Book
12/2015
1st Edition
Oxford University Press
€90.00
Available for download
Person
Barbara S. Giesser, MD is Clinical Director at UCLA MS Clinical Service, David Geffen School of Medicine, Los Angles, CA.
Content
Part 1: Historical Background ; Chapter 1: The History of Multiple Sclerosis: From the Age of Description to the Age of Therapy ; T. Jock Murray ; Part 2: Basic Science ; Chapter 2: Genetics and Epidemiology in Multiple Sclerosis ; Gabriele C. DeLuca, Richard L. Yates and A. Dessa Sadovnick ; Chapter 3: Neurophysiology of Multiple Sclerosis ; Jefferson C. Slimp ; Chapter 4: Immunology of Multiple Sclerosis ; Laura Piccio and Anne H. Cross ; Chapter 5: Taking a Microscopic Look at Multiple Sclerosis ; Yong Guo and Claudia F. Lucchinetti ; Part 3: Diagnosis and Prognosis ; Chapter 6: Diagnosis of Multiple Sclerosis ; Loren A. Rolak ; Chapter 7: Neuroimaging in Multiple Sclerosis ; Megan Esch & Nancy L. Sicotte ; Chapter 8: Cerebrospinal Fluid Profile Supporting a Clinical Definite Multiple Sclerosis Diagnosis ; Mark Freedman and Mohammed Abdoli ; Chapter 9: Evoked Potentials ; Marc R. Nuwer ; Chapter 10: Temporal and Clinical Course of Multiple Sclerosis ; Erica Grazioli, Cornelia Mihai, and Bianca Weinstock-Guttman ; Chapter 11: Outcome Measures in Multiple Sclerosis ; Robert M. Herndon ; Part 4: Clinical Manifestations ; Chapter 12: Neuro-Ophthalmologic Manifestations of Multiple Sclerosis ; Shin C. Beh, Elliot M. Frohman, and Teresa Frohman ; Chapter 13: Cerebellar and Brainstem Dysfunction in Multiple Sclerosis ; Angeli S. Mayadev and George H. Kraft ; Chapter 14: Disorders of Mobility in Multiple Sclerosis ; Scott Campea and Jodie K. Haselkorn ; Chapter 15: Management of Urinary and Bowel Dysfunction in Patients with Multiple Sclerosis ; Ja-Hong Kim and Judy M. Choi ; Chapter 16: Assessment and Treatment of Sexual Dysfunction in Multiple Sclerosis ; Frederick W. Foley ; Chapter 17: Gender and Reproductive Issues in Multiple Sclerosis ; Rhonda Voskuhl and Barbara S. Giesser ; Chapter 18: Cognitive Impairment and Mood Disturbances ; Nicholas G. LaRocca ; Chapter 19: Multiple Sclerosis and Pain ; Norman S. Namerow ; Chapter 20: Fatigue in Multiple Sclerosis ; Vikram Bhise, Leigh Charvet, and Lauren Krupp ; Chapter 21: Sleep Disorders in Multiple Sclerosis ; Tiffany J. Braley and Alon Y. Avidan ; Chapter 22: Pediatric Multiple Sclerosis ; J.M. Tillema, J. Graves, L.A. Benson, G.S. Aaen, A. Belman, J. Parrish, B. Weinstock-Guttman, L. Krupp, T. Chitnis, and E. Waubant, ; Part 5: Therapeutics ; Chapter 23: Neuromyelitis Optica Spectrum Disorders ; Dean M. Wingerchuk ; Chapter 24: Multiple Sclerosis Nursing ; Kirstin Nygren and Gail Hartley ; Chapter 25: Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis ; Jessica F. Robb and Lawrence M. Samkoff ; Chapter 26: Immunosuppressive and Novel Therapies ; Barbara S. Giesser ; Chapter 27: Complementary and Alternative Medicine in Multiple Sclerosis ; Allen C. Bowling ; Part 6: Psychosocial Issues ; Chapter 28: Living with Multiple Sclerosis: The Psychosocial Challenges for Patients and Their Families Rosalind C. Kalb ; Chapter 29: Employment and Career Development Considerations ; Steven W. Nissen and Phillip D. Rumrill, Jr. ; Chapter 30: Legal Planning Issues ; Laura D. Cooper, Esq. ; Part 7: Research ; Chapter 31: Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials ; Stephen Krieger, Ilana Katz Sand, Svenja Oynhausen, and Aaron Miller ; Chapter 32: Basic Science in Multiple Sclerosis: Progress and Promise ; Wendy Gilmore and Leslie P. Weiner